Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients

Blood

Volumn 88, Issue 3, 1996, Pages 881-886

  Mesters, Rolf M ^b   Mannucci, Pier Mannuccio ^b   Coppola, Raffaella ^b   Keller, Thomas ^b   Ostermann, Helmut ^b   Kienast, Jochen ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEVER; HUMAN; MALE; NEUTROPENIA; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

EID: 0029743427     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.881.bloodjournal883881     Document Type: Article

References (32)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864, 1992
2. Glauser MP, Zanetti G, Baumgartner JD, Cohen J: Septic shock: Pathogenesis. Lancet 338:732, 1991
3. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101:816, 1992
4. Levi M, ten Cate H, van der Poll T, van Deventer SJH: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975, 1993
5. Van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520, 1990
6. Van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622, 1990
7. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33:127, 1991
8. Pixley RA, De La Cadena R, Page JD, Kaufman N, Wyshock EG, Chang A, Taylor FB, Colman RW: The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. J Clin Invest 91:61, 1993
9. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HS, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93:114, 1994
10. Biemond BJ, Levi M, ten Cate H, Soule HR, Morris LD, Foster DL, Bogowitz CA, van der Poll T, Büller HR, ten Cate JW: Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/ VIIa. Thromb Haemost 73:223, 1995
11. Bone RC: Gram-positive organisms and sepsis. Arch Int Med 154:26, 1994
12. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U: Measurement of basal levels of factor Vila in hemophilia A and B patients. Blood 80:25, 1992
13. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
14. Esnouf MP, Ford RP, Burgess AI: The immunoassay of activated factor XII (Hageman factor) in human plasma. J Immunol Methods 1996 (in press)
15. Pizzo PA: Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323, 1993
16. Bauer KA: Laboratory markers of coagulation activation. Arch Pathol Lab Med 117:71, 1993
17. Ruf W, Edgington TS: Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa. Proc Natl Acad Sci USA 88:8430, 1991
18. Carson SD, Konigsberg WH: Cadmium increases tissue factor (coagulation factor III) activity by facilitating its reassociation with lipids. Science 208:307, 1980
19. Morrissey JH, Fair DS, Edgington TS: Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res 52:247, 1988
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
21. Coppola R, Tombesi S, Valentini P, Alborali S, Albertini A, Mannucci PM: Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein. Thromb Res 68:283, 1992
22. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI: Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 88:708, 1991
23. Lawson JH, Mann KG: Cooperative activation of human factor IX by the human extrinsic pathway of coagulation. J Biol Chem 266:11317, 1991
24. Arabruso DR, Leonard BD, Bies RD, Jacobson L, Hathaway WE, Reeve EB: Antithrombin HI deficiency: Decreased synthesis of a biochemically normal molecule. Blood 60:78, 1982
25. Carrell RW, Owen MC: Plakalbumin, alpha,-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature 317:730, 1985
26. Seitz R, Wolf M, Egbrink R, Radtke KP, Liesenfeld A, Pittmer P, Havemann K: Participation and interactions of neutrophil elastase in hemostatic disorders of patients with severe infections. Eur J Haematol 38:231, 1987
27. Ostermann H, Rothenburger M, Mesters RM, van de Loo J, Kienast J: Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy. Br J Haematol 88:332, 1994
28. Warr TA, Rao LVM, Rapaport SI: Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease. Blood 74:994, 1989
29. Sandset PM, Roise O, Aasen AO, Abildgaard U: Extrinsic pathway inhibitor in postoperative/posttraumatic septicemia: Increased levels in fatal cases. Haemostasis 19:189, 1989
30. Brandtzaeg P, Sandset PM, Joe GB, Ovstbo R, Kierulf P, Abildgaard U: Quantitative relation between plasma endotoxin, antithrombin, protein C, extrinsic coagulation pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 55:459, 1989
31. Hellgren M, Egberg N, Eklund J: Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients. Intensive Care Med 10:23, 1984
32. Wilson RF, Mammen EF, Robson MC, Heggers JP, Soullier G, Depoli PA: Antithrombin, prekallikrein and fibronectin levels in surgical patients. Arch Surg 121:635, 1986